Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS

Completed · Phase 2

Conditions studied: AIDS Dementia Complex

In brief

This project will investigate the ability of a novel MRI contrast agent to identify and quantitate ongoing monocyte/macrophage (M/MΦ)-mediated inflammation in the brains of HIV-infected individuals.

Key facts

Study ID
NCT02678767
Run by
Beau Nakamoto
People needed
30
Starts
2015-02-01
Expected to finish
2017-09-01
Last updated by the study team
2017-10-27

Who can join

Age: 40 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.